Tag: venture capital
-
Infographic – Machine Learning Grabs Most A.I. Investments
So far this year, machine learning applications and platforms are gaining the most investment dollars worldwide for A.I., this weekend’s infographic.
-
Start-Up to Use Crispr for Heart Disease, Gains $59M
A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease.
-
Synthetic Soft Tissue Developed for Surgery
Researchers developed a synthetic soft tissue for plastic and reconstructive surgery that in animal tests looks and performs more like real tissue.
-
Infographic – Venture Deals Cool Off in Q1 2019
Venture capital investments worldwide declined in the first quarter of 2019, compared to the near record-setting pace of the last 3 months of 2018.
-
Radiation-Antibody Biotech Raises $105M in Venture Funds
A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing.
-
Respiratory Vaccine Maker Raises $3.4M in Seed Funds
A company developing vaccines that protect against respiratory diseases in vulnerable populations is raising new seed funds to advance its lead product into clinical trials.
-
Start-Up Creating Off-the-Shelf Stem Cell Therapies
A new company is licensing technology from the lab of its co-founder at Harvard University to develop stem cell therapies for any recipients, without causing immune reactions.
-
Infographic – Germany Beats U.K. in Top Venture Funds
A new analysis from technology market intelligence company GlobaData, based in London, shows the top 2 enterprises attracting venture financing in Europe during 2018 were German companies.
-
Venture Funds, Mergers in A.I. Up Sharply in 2018
Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows.
-
Start-Up Raises $10.5M for Precision Immunotherapies
A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round.